Vinorelbine
Primary Mediastinal Large B-cell Lymphoma
Chinese PLA General HospitalPhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
1 Active assets in the Primary Mediastinal Large B-cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Omeprazole Epizyme, Inc. | Phase 2 | BB |
LACTULOSE National Cancer Institute (NCI) | Phase 2 | B |
DOCUSATE SODIUM National Cancer Institute (NCI) | Phase 2 | B |
Prochlorperazine National Cancer Institute (NCI) | Phase 2 | B |
Zofran National Cancer Institute (NCI) | Phase 2 | B |
View all 12 →
Same molecule, other indications
Vinorelbine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →